Cleared Traditional

K072823 - MERILAS 532A

K072823 is an FDA 510(k) clearance for MERILAS 532A, manufactured by Meridian AG. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 73-day FDA review.

K072823 · Meridian AG · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
73d
Days
Class 2
Risk

K072823 is an FDA 510(k) clearance for the MERILAS 532A. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Meridian AG (Littleton, US). The FDA issued a Cleared decision on December 14, 2007 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Meridian AG devices

FDA 510(k) Submission Details - K072823

510(k) Number K072823 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2007
Decision Date December 14, 2007
Days to Decision 73 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 110d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 85
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K072823.
VISUMAX LASER KERATOME
K100253 · Carl Zeiss Meditec, AG · Jul 2010
SUPRA 577.Y LASER
K091581 · Quantel Medical · Jun 2009
SUPRA TWIN OPHTHALMIC LASER PHOTOCOAGULATOR
K081946 · Quantel Medical · Mar 2009
NEXT GENERATION LASER
K062624 · Alcon Laboratories · Nov 2007
SUPRA OPHTHALMIC LASER PHOTOCOAGULATOR
K070776 · Quantel Medical · Apr 2007
FAMILY OF SELECTA OPHTHALMIC LASER SYSTEMS (SELECTA 1064, SELECTA SLT, SELECTA DUO), DELIVERY DEVICE AND ACCESSORIES
K051944 · Lumenis, Inc. · Sep 2005